
Supramolecular Chemistry p. 604 - 617,14 (2012)
Update date:2022-08-03
Topics:
Lennartson, Anders
Nelson, Jane
McKenzie, Christine J.
McKee, Vickie
Arthurs, Michael
Protocols for accessing the [2+3] and [2+2] tren + thiophenolate-based cryptands and macrocycles, respectively, have been devised; however, a propensity towards incomplete crypt formation is clear: Cd(II)2, Mn(II)2, Ni(II)2 and Pd(II)2 complexes of the [2+2] bibrachial systems in which one arm of each of the tren head groups is pendant were isolated in attempts to make the crypts. The Mn(II)2 complex can be used in transmetallation reactions and these probably occur in a stepwise fashion for the heavier, softer metal ions since the plausible intermediates Mn(II)M(II), M = Cd, Pd, were identified. There is evidence for the formation of [2+3] cryptand systems using templating Ag(I) and Cd(II); however, reaction conditions need to be strictly controlled to ensure isolation of either the [2+3] cryptand or the [2+2] macrocyclic complex since ensuing reactions leading to intractable oligomers are competing. The template and transmetallation experiments described here emphasise the relatively greater hydrolytic sensitivity of the thiophenol-derived imino macrocycles and crypts than their better-known phenol-based counterparts.
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Synochem Ingredients Corp., Ltd.
Contact:+86-512-5636 2180
Address:Zhangjiagang Free Trade Zone
SHENYANG COMEBOARD TECHNOLOGY CO., LTD
Contact:+86-24-25724626
Address:Room2210,Tianbao International Building,No.8-1 Weigong South Street,Tiexi District,Shenyang,China
Changzhou Welton Chemical Co., Ltd,
Contact:0086-519-85910828,85920537,85912897
Address:No.8 Jinlong Road, Binjiang Park, Changzhou, Jiangsu, China.
Doi:10.1039/c2ob26105g
(2012)Doi:10.1002/rcm.6330
(2012)Doi:10.1016/j.steroids.2012.05.003
(2012)Doi:10.1002/hc.20042
(2004)Doi:10.1002/ardp.18942320106
(1894)Doi:10.1016/j.tet.2012.03.081
(2012)